Citigroup released a research report maintaining its positive outlook on FANGZHOU JIANKE (06086), reiterating a "Buy" rating and setting a target price of HK$8.5. The company issued a positive profit alert, forecasting last year's revenue to be between 3.5 billion and 3.55 billion yuan, representing a 30% year-on-year increase. It also projected a turnaround to profitability, with an estimated net profit ranging from 7 million to 10 million yuan. Citigroup stated that these results were largely in line with expectations, as the bank had previously forecasted a 28% revenue growth for 2025 and an estimated net profit of 6 million yuan. Management attributed the rapid revenue growth to an increase in the number of patients and doctors on its platform, while the return to profitability was primarily driven by revenue expansion and a reduction in share-based compensation expenses. FANGZHOU JIANKE's shares opened sharply higher this morning (26th), surging 10.25%, and reached an intraday high of HK$4.19. By the midday close, the stock was trading at HK$4.01, up 41.7%, with a trading volume of 118 million shares and a turnover of HK$452 million.